Parent relationship quality ‐ not reported · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Parental self‐harm ‐ post‐intervention ‐ not reported · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Parent‐child relationship or assessment of parenting · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
1 finding from 1 review
Parenting skills; postintervention · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
1 finding from 1 review
Trauma‐related symptoms ‐ post‐interventionb · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
1 finding from 1 review
Psychological wellbeing ‐ post‐interventiond · for parents who are experiencing CPTSD symptoms or have experienced maltreatment in their childhood
1 finding from 1 review
Major adverse events · Adults with overactive bladder (OAB)
1 finding from 1 review
Number of minor adverse events · Adults with overactive bladder (OAB)
1 finding from 1 review
Presence or absence of urinary urgency · Adults with overactive bladder (OAB)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Episodes of urinary incontinence in a 24‐hour period · Adults with overactive bladder (OAB)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Daytime urinary frequency · Adults with overactive bladder (OAB)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Episodes of nocturia · Adults with overactive bladder (OAB)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Erectile function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy showed no clear difference in erectile function (sexually‐active men only) compared with transurethral resection of the prostate (low certainty).
1 finding from 1 review
Ejaculatory function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy may leads to lower ejaculatory function (sexually‐active men only) compared with transurethral resection of the prostate (low certainty).
1 finding from 1 review
Recurrence of any episodes at one year (active suicidal behavior) · bipolar disorder
It is very uncertain whether lamotrigine changes recurrence of any episodes at one year (active suicidal behavior) compared with lithium (very low certainty).
1 finding from 1 review
Recurrence of any episodes at one year (active suicidal behavior) · bipolar disorder
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Erectile function · men with benign prostatic hyperplasia
1 finding from 1 review
Ejaculatory function · men with benign prostatic hyperplasia
1 finding from 1 review
All‐cause mortality (main analysis ‐ active cancer) · patients with cancer with venous thromboembolism
Low molecular weight heparin secondary prophylaxis showed no clear difference in all‐cause mortality (main analysis ‐ active cancer) compared with vitamin K antagonist secondary prophylaxis (low certainty).
1 finding from 1 review
Recurrent venous thromboembolism (main analysis ‐ active cancer) · patients with cancer with venous thromboembolism
Low molecular weight heparin secondary prophylaxis probably leads to lower recurrent venous thromboembolism (main analysis ‐ active cancer) compared with vitamin K antagonist secondary prophylaxis (moderate certainty).
1 finding from 1 review